NEW YORK, Oct 5 (Reuters) - Zars Pharma Inc, a Salt Lake City pharmaceutical company, said on Friday it had withdrawn its plans for an initial public offering.
The company, in a filing with the U.S. Securities and Exchange Commission. cited “market conditions” as the reason for the withdrawal.
In August, the company filed to sell 5 million shares for $14 to $16 each. It had planned to list its shares on Nasdaq.
The offering was led by Cowen & Co and CIBC World Markets. (Reporting by Lilla Zuill)